Refractory Marginal Zone Lymphoma

DBCOND0092876Hematologic Neoplasms

Refractory Marginal Zone Lymphoma is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Marginal zone lymphoma refractory
Classified under
Indicated drugs

Resolves to

Vocabularies
MedDRA10077534UMLSC4087393

What you can answer from here — as of October 31, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
20Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Refractory Marginal Zone Lymphoma share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In